Literature DB >> 2991330

Detection of cytomegalovirus antibody with latex agglutination.

S P Adler, M McVoy, V G Biro, W J Britt, P Hider, D Marshall.   

Abstract

Transfusion-acquired cytomegalovirus (CMV) infections should be prevented in seronegative immunocompromised patients by providing blood products from donors who are also seronegative. Latex agglutination was investigated as a simple and rapid method for detecting antibody against CMV. Latex beads were coated with CMV antigen, incubated for 8 min at room temperature with 25 microliter of sera, and examined for agglutination. The sensitivity and specificity of latex agglutination was compared with that of indirect hemagglutination (IHA, Cetus Corp., Emeryville, Calif.) and enzyme immunoassay (EIA) with sera from 604 random blood donors or patients. Of 327 serum samples shown to be seronegative by EIA and IHA, 327 had a latex agglutination titer of less than 1:4 (specificity, 100%). Of 236 serum samples with detectable antibody by EIA and IHA, 228 had a latex agglutination titer of 1:4 or greater (sensitivity, 97%). Plasma collected with EDTA, heparin, or citrate was satisfactory for latex agglutination. Latex agglutination results correlated quantitatively with those of EIA, and the test also detected fourfold or greater rises in antibody with paired sera from six patients with posttransfusion CMV infections. Latex agglutination is a sensitive and specific assay that is rapid and simple to perform and should be effective in selecting seronegative blood donors to prevent posttransfusion CMV infections in seronegative recipients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991330      PMCID: PMC268323          DOI: 10.1128/jcm.22.1.68-70.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Comparison of five methods of cytomegalovirus antibody screening of blood donors.

Authors:  P H Phipps; L Grégoire; E Rossier; E Perry
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

2.  Improved indirect hemagglutination test for cytomegalovirus using human O erythrocytes in lysine.

Authors:  A S Yeager
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

3.  Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.

Authors:  S P Adler; L T Lawrence; J Baggett; V Biro; D E Sharp
Journal:  Transfusion       Date:  1984 Jul-Aug       Impact factor: 3.157

4.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.

Authors:  A S Yeager; F C Grumet; E B Hafleigh; A M Arvin; J S Bradley; C G Prober
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

Review 5.  Transfusion-associated cytomegalovirus infections.

Authors:  S P Adler
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

6.  Cytomegalovirus infections in neonates acquired by blood transfusions.

Authors:  S P Adler; T Chandrika; L Lawrence; J Baggett
Journal:  Pediatr Infect Dis       Date:  1983 Mar-Apr
  6 in total
  15 in total

1.  Results of a quality assurance program for detection of cytomegalovirus infection in the pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus infection study.

Authors:  G J Demmler; A Istas; K A Easley; A Kovacs
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Comparison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipients.

Authors:  H Miller; B McCulloch; M P Landini; E Rossier
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

3.  Comparison of four techniques for detection of antibodies to cytomegalovirus.

Authors:  Y J Kraat; R M Hendrix; M P Landini; C A Bruggeman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

4.  [Experiences with a "rapid test" in detecting antibodies to cytomegalovirus].

Authors:  H Milbradt
Journal:  Klin Wochenschr       Date:  1989-08-17

5.  Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service.

Authors:  D S Leland; K A Barth; E B Cunningham; J Jansen; G J Tricot; M L French
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

6.  Microparticle enzyme immunoassay for determination of immunoglobulin G antibodies to human cytomegalovirus.

Authors:  G Duverlie; C Roussel; M Driencourt; J Orfila
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

7.  Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.

Authors:  S W Chou; K M Scott
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Latex agglutination test for detecting CMV antibodies in patients awaiting bone marrow transplantation.

Authors:  P R Hunter; E Evans; S J May
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

9.  Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus.

Authors:  J Dolan; J D Briggs; G B Clements
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

10.  Evaluation of a latex particle agglutination assay for the detection of cytomegalovirus antibody in patient serum.

Authors:  D A Hursh; A D Abbot; R Sun; J P Iltis; D H Rice; C A Gleaves
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.